The global burden of cancer: priorities for prevention
- PMID: 19934210
- PMCID: PMC2802672
- DOI: 10.1093/carcin/bgp263
The global burden of cancer: priorities for prevention
Abstract
Despite decreases in the cancer death rates in high-resource countries, such as the USA, the number of cancer cases and deaths is projected to more than double worldwide over the next 20-40 years. Cancer is now the third leading cause of death, with >12 million new cases and 7.6 million cancer deaths estimated to have occurred globally in 2007. By 2030, it is projected that there will be approximately 26 million new cancer cases and 17 million cancer deaths per year. The projected increase will be driven largely by growth and aging of populations and will be largest in low- and medium-resource countries. Under current trends, increased longevity in developing countries will nearly triple the number of people who survive to age 65 by 2050. This demographic shift is compounded by the entrenchment of modifiable risk factors such as smoking and obesity in many low-and medium-resource countries and by the slower decline in cancers related to chronic infections (especially stomach, liver and uterine cervix) in economically developing than in industrialized countries. This paper identifies several preventive measures that offer the most feasible approach to mitigate the anticipated global increase in cancer in countries that can least afford it. Foremost among these are the need to strengthen efforts in international tobacco control and to increase the availability of vaccines against hepatitis B and human papilloma virus in countries where they are most needed.
Figures
Similar articles
-
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2. Lancet. 1997. PMID: 9167458
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
Global cancer statistics, 2012.CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4. CA Cancer J Clin. 2015. PMID: 25651787
-
Projections of global mortality and burden of disease from 2002 to 2030.PLoS Med. 2006 Nov;3(11):e442. doi: 10.1371/journal.pmed.0030442. PLoS Med. 2006. PMID: 17132052 Free PMC article.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
Cited by
-
TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway.Oncol Lett. 2016 May;11(5):2965-2970. doi: 10.3892/ol.2016.4329. Epub 2016 Mar 16. Oncol Lett. 2016. PMID: 27123047 Free PMC article.
-
Proanthocyanidins reduce cellular function in the most globally diagnosed cancers in vitro.PeerJ. 2020 Sep 15;8:e9910. doi: 10.7717/peerj.9910. eCollection 2020. PeerJ. 2020. PMID: 32983646 Free PMC article.
-
A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.Cancer Res. 2016 Dec 15;76(24):7208-7218. doi: 10.1158/0008-5472.CAN-16-1681. Epub 2016 Oct 14. Cancer Res. 2016. PMID: 27742685 Free PMC article.
-
Smart Stimuli-Responsive Liposomal Nanohybrid Systems: A Critical Review of Theranostic Behavior in Cancer.Pharmaceutics. 2021 Mar 8;13(3):355. doi: 10.3390/pharmaceutics13030355. Pharmaceutics. 2021. PMID: 33800292 Free PMC article. Review.
-
Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis.Onco Targets Ther. 2016 Apr 20;9:2403-8. doi: 10.2147/OTT.S104181. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143935 Free PMC article.
References
-
- American Cancer Society. Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007.
-
- IARC. Lyon: IARC Press; 2008. World Cancer Report, 2008. Boyle,P. and Levin,B.E. (eds),
-
- Bray F, et al. Predicting the future burden of cancer. Nat. Rev. Cancer. 2006;6:63–74. - PubMed
-
- Shafey O, et al. The Tobacco Atlas. 3rd edn. Atlanta, GA: American Cancer Society; 2009. p. 128.
-
- Mackay J, et al. The Tobacco Atlas. 2nd edn. Atlanta, GA: American Cancer Society; 2006.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources